Roche sees positive data in lung cancer immunotherapy first

Roche announced positive survival data in a trial that the drugmaker hopes will yield the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form of lung cancer.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news